Olivia Brayer
Stock Analyst at Cantor Fitzgerald
(4.11)
Main Sectors:
Top Industries:
17 Stocks
Name | Action | PT | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
CTMX CytomX Therapeutics | Initiates Coverage On: Overweight | 6 | 3.3 | 81.82% | 1 | Sep 22, 2025 | |
GOSS Gossamer Bio | Reiterates: Overweight | n/a | n/a | n/a | 1 | Sep 11, 2025 | |
UTHR United Therapeutics | Maintains: Overweight | 405 525 | 453.07 | 15.88% | 2 | Sep 10, 2025 | |
VRNA Verona Pharma | Maintains: Overweight | 90 100 | 106.79 | -6.36% | 1 | Jun 11, 2025 | |
VNDA Vanda Pharmaceutical... | Assumes: Overweight | 13 | 5.43 | 139.41% | 1 | May 14, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 90 90 | 55.43 | 62.37% | 15 | Feb 20, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 480 480 | 403.12 | 19.07% | 22 | Feb 11, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 50 55 | 45.44 | 21.04% | 9 | Feb 4, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 80 80 | 112.69 | -29.01% | 10 | Dec 11, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | n/a | n/a | n/a | 1 | Nov 14, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 1015 1015 | 600 | 69.17% | 8 | Oct 23, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 405 405 | 297.89 | 35.96% | 2 | Oct 22, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 220 220 | 456.35 | -51.79% | 23 | Oct 11, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 10 10 | 11.35 | -11.89% | 5 | Sep 16, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 7 7 | 5.76 | 12.85% | 4 | May 9, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 72 | 67.74 | 6.29% | 1 | Apr 13, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 56 21 | n/a | n/a | 2 | Feb 23, 2023 |